← SynDRA
ML-130
SynDRA canonical compound SYN0062942 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Mechanism of action | NOD1 inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- NOD1 INHIBITOR
- NOD2 INHIBITOR
Cross-references
Synonyms
- 1-(4-methylbenzenesulfonyl)-1H-1,3-benzodiazol-2-amine
- RefChem:425850
- Nodinitib-1
- ML130
- Noditinib-1
- 1-Tosyl-1H-benzo[d]imidazol-2-amine
- 1-(4-methylphenyl)sulfonylbenzimidazol-2-amine
- ML130 (Nodinitib-1)
- MFCD04322367
- ML130;CID-1088438
- MLS001201458
- 1-(Toluene-4-sulfonyl)-1H-benzoimidazol-2-ylamine
- SMR000523991
- 1-[(4-Methylphenyl)sulfonyl]-1H-benzimidazol-2-amine;
- Noditinib
- BAS 07162070
- MLS002639479
- GTPL8887
- orb1300633
- SCHEMBL10107599
- SCHEMBL29399999
- (1-tosylbenzimidazol-2-yl)amine
- BDBM59542
- CHEBI:93561
- cid_1088438
- 1-[(4-Methylbenzene)sulfonyl]-1H-1,3-benzodiazol-2-amine
- GLXC-02629
- HMS2819O03
- HMS3651B21
- Nodinitib-1, >=98% (HPLC)
- ZGB26447
- CCG-25324
- EBC-47468
- ML130?
- s2863
- AKOS000641831
- CS-6462
- SB19544
- compound 1c [PMID: 22003428]
Look up ML-130 in the interactive SynDRA portal →